The Journal of Organic Chemistry
Article
8.4, J = 1.1, 1H), 7.23 (d, J = 8.2, 2H), 7.39 (ddd, J = 8.0, J = 7.5, J =
1.1, 1H), 7.55 (ddd, J = 8.4, J = 7.5, J = 1.5, 1H), 7.65 (d, J = 8.2, 2H),
7.87 (dd, J = 8.0, J = 1.5, 1H), 8.18 (s, 1H); 13C NMR (CDCl3) δ 21.8,
114.9, 124.8, 128.5, 129.1, 129.9, 130.6, 131.3, 131.9, 133.0, 135.3,
135.7, 145.8, 149.9, 153.3; IR 1678, 1607; HRMS m/z calcd for
C17H15N2O3S+ [M + H]+ 327.0798, found 327.0800.
= 8.2, 2H), 7.52 (d, J = 14.3, 1H), 7.79−7.85 (m, 4H), 7.92−7.98 (m,
3H); 13C NMR (CDCl3) δ 21.8, 119.0, 124.6, 127.8, 128.8, 130.1,
131.3, 135.6, 138.2, 144.5, 165.1; IR 1796, 1723, 1622; HRMS m/z
calcd for C17H14NO4S+ [M + H]+ 328.0638, found 328.0635.
3c (>99:1 E/Z, 93 mg, 80%), 5′-O-acetyl-3′-azido-3′-deoxy-3-[(E)-
2-(4-methylphenylsulfonyl)ethenyl]thymidine. White solid; mp 98−
1
100 °C; Rf = 0.30 (CH2Cl2/MeOH, 99:1); H NMR (CDCl3) δ 1.94
2f (95:5 Z/E, 50 mg, 86%, with 0.03 equiv of Et3N). Data for
chromatographically pure 2′,3′,5′-tri-O-acetyl-1-[(Z)-2-(4-
methylphenylsulfonyl)ethenyl]inosine. White solid; mp 96−98 °C;
(s, 3H), 2.12 (s, 3H), 2.34−2.39 (m, 1H), 2.42 (s, 3H), 2.46−2.57 (m,
1H), 4.06−4.09 (m, 1H), 4.18−4.22 (m, 1H), 4.32 (dd, J = 12.4, J =
3.6, 1H), 4.38 (dd, J = 12.4, J = 4.4, 1H), 6.05 (t, J = 6.1, 1H), 7.31 (m,
3H), 7.71 (d, J = 14.3, 1H), 7.78 (d, J = 8.0, 2H), 8.37 (d, J = 14.3,
1H); 13C NMR (CDCl3) δ 13.5, 20.9, 21.7, 37.9, 60.4, 63.2, 82.3, 87.0,
110.1, 123.3, 127.8, 130.0, 131.8, 134.2, 138.1, 144.5, 149.1, 161.6,
170.3; IR 2109, 1739, 1718, 1651; HRMS m/z calcd for
C21H24N5O7S+ [M + H]+ 490.1391, found 490.1387.
1
Rf = 0.45 (CH2Cl2/MeOH, 95:5); H NMR (CDCl3) δ 2.11 (s, 3H),
2.16 (s, 6H), 2.39 (s, 3H), 4.36−4.49 (m, 3H), 5.57 (t, J = 5.0, 1H),
5.81 (t, J = 5.4, 1H), 6.16 (d, J = 5.4, 1H), 6.56 (d, J = 9.2, 1H), 7.29
(d, J = 8.2, 2H), 7.36 (d, J = 9.2, 1H), 7.72 (d, J = 8.2, 2H), 7.96 (s,
1H), 8.31 (s, 1H); 13C NMR (CDCl3) δ 20.5, 20.6, 20.9, 21.8, 63.1,
70.6, 73.5, 80.6, 86.8, 122.7, 125.2, 127.9, 130.2, 135.0, 137.2, 139.4,
145.2, 145.3, 146.1, 155.1, 169.4, 169.7, 170.4; IR 1742, 1704, 1631;
HRMS m/z calcd for C25H27N4O10S+ [M + H]+ 575.1442, found
575.1447.
3d (>99:1 E/Z, 83 mg, 96%), N-[(E)-2-(4-methylphenylsulfonyl)-
ethenyl]-2-pyridone. White solid; mp 195−196 °C; Rf = 0.63
1
(CH2Cl2/MeOH, 98:2); H NMR (CDCl3) δ 2.44 (s, 3H), 6.23 (br
2g (>99:1 Z/E, 64 mg, 87%, with 0.03 equiv of Et3N), (S)-N-[(Z)-2-
(4-methylphenylsulfonyl)ethenyl]-2,10-camphorsultam. White
solid; mp 131−133 °C; Rf = 0.54 (CH2Cl2/MeOH, 99.5:0.5); 1H
NMR (CDCl3) δ 0.91 (s, 3H), 0.94 (s, 3H), 1.41−1.46 (m, 1H),
1.53−1.59 (m, 1H), 1.90−1.97 (m, 3H), 2.25 (dd, J = 13.7, J = 8.0,
1H), 2.36−2.42 (m, 1H), 2.44 (s, 3H), 3.31 (d, J = 13.8, 1H), 3.36 (d,
J = 13.8, 1H), 4.38 (dd, J = 7.9, J = 4.8, 1H), 5.45 (d, J = 9.8, 1H), 6.54
(d, J = 9.8, 1H), 7.33 (d, J = 8.4, 2H), 7.79 (d, J = 8.4, 2H); 13C NMR
(CDCl3) δ 20.1, 20.2, 21.8, 27.0, 31.9, 35.0, 44.4, 48.3, 50.0, 52.7, 68.1,
111.7, 126.3, 127.5, 130.0, 139.6, 144.5; IR 1608; HRMS m/z calcd for
t, J = 6.8, 1H), 6.58 (br d, J = 9.1, 1H), 7.06 (d, J = 14.1, 1H), 7.28−
7.37 (m, 4H), 7.82 (d, J = 8.3, 2H), 8.22 (d, J = 14.1, 1H); 13C NMR
(CDCl3) δ 21.8, 108.0, 120.1, 122.9, 127.9, 130.2, 133.0, 137.3, 137.8,
140.0, 144.8, 161.3; IR 1682, 1625; HRMS m/z calcd for
C14H14NO3S+ [M + H]+ 276.0689, found 276.0690.
3e (>99:1 E/Z, 86 mg, 84%), 1-[(E)-2-(4-methylphenylsulfonyl)-
ethenyl]-2-quinoxalinone. White solid; mp 168−170 °C; Rf = 0.66
(CH2Cl2/EtOAc, 1:1); 1H NMR (CDCl3) δ 2.44 (s, 3H), 7.36 (d, J =
8.2, 2H), 7.47 (ddd, J = 8.1, J = 7.2, J = 1.3, 1H), 7.59 (dd, J = 8.6, J =
1.4, 1H), 7.65 (ddd, J = 8.6, J = 7.2, J = 1.6, 1H), 7.84 (d, J = 8.4, 2H),
7.88 (d, J = 13.7, 1H), 8.07 (d, J = 13.7, 1H), 8.21 (s, 1H); 13C NMR
(CDCl3) δ 21.8, 114.4, 125.9, 127.2, 127.9, 130.3, 130.7, 131.3, 131.4,
131.8, 133.4, 137.4, 145.0, 150.3, 154.0; IR 1681, 1612; HRMS m/z
calcd for C17H15N2O3S+ [M + H]+ 327.0798, found 327.0802.
3f (>99:1 E/Z, 52 mg, 90%), 2′,3′,5′-tri-O-acetyl-1-[(E)-2-(4-
methylphenylsulfonyl)ethenyl]inosine. White solid; mp 108−109 °C;
+
C19H26NO4S2 [M + H]+ 396.1298, found 396.1293.
2h (98:2 Z/E, 153 mg, 96%, with 0.03 equiv of Et3N). Data for
chromatographically pure N-[(Z)-2-(4-methylphenylsulfonyl)-
ethenyl]-1,8-naphthosultam. White solid; mp 188−190 °C; Rf =
1
0.24 (CH2Cl2); H NMR (CDCl3) δ 2.38 (s, 3H), 6.65 (d, J = 8.6,
1H), 6.82 (d, J = 8.6, 1H), 7.17 (dd, J = 6.9, J = 1.1, 1H), 7.27 (d, J =
8.3, 2H), 7.59−7.68 (m, 2H), 7.77 (dd, J = 8.1, J = 7.2, 1H), 7.85 (d, J
= 8.3, 2H), 7.97 (d, J = 7.2, 1H), 8.13 (d, J = 8.1, 1H); 13C NMR
(CDCl3) δ 21.8, 108.4, 120.2, 120.2, 120.6, 127.8, 128.1, 128.4, 129.5,
129.5, 130.0, 130.9, 131.8, 132.1, 135.7, 137.2, 145.3; IR 1615; HRMS
1
Rf = 0.51 (CH2Cl2/MeOH, 95:5); H NMR (CDCl3) δ 2.09 (s, 3H),
2.12 (s, 3H), 2.14 (s, 3H), 2.44 (s, 3H), 4.35 (dd, J = 12.3, J = 4.6,
1H), 4.39−4.47 (m, 2H), 5.54 (t, J = 5.2, 1H), 5.81 (t, J = 5.4, 1H),
6.08 (d, J = 5.2, 1H), 7.36 (d, J = 8.2, 2H), 7.42 (d, J = 14.1, 1H), 7.82
(d, J = 8.2, 2H), 7.95 (s, 1H), 8.10 (s, 1H), 8.14 (d, J = 14.1, 1H); 13C
NMR (CDCl3) δ 20.5, 20.7, 20.9, 21.8, 63.0, 70.6, 73.6, 80.6, 86.5,
124.5, 127.9, 128.9, 130.3, 132.6, 136.2, 138.5, 145.9, 147.5, 147.6,
155.3, 169.4, 169.7, 170.4; IR 1748, 1712; HRMS m/z calcd for
C25H27N4O10S+ [M + H]+ 575.1442, found 575.1447.
+
m/z calcd for C19H16NO4S2 [M + H]+ 386.0515, found 386.0526.
2i (>99:1 Z/E, 103 mg, 90%, with 0.2 equiv of NaH), N-[(Z)-2-(4-
methylphenylsulfonyl)ethenyl]saccharin. White solid; mp 168−170
1
°C; Rf = 0.55 (hexanes:EtOAc, 1:1); H NMR (DMSO-d6) δ 2.41 (s,
3H), 6.91 (d, J = 8.4, 1H), 7.36 (d, J = 8.4, 1H), 7.48 (d, J = 8.3, 2H),
7.80 (d, J = 8.3, 2H), 8.08 (td, J = 7.5, J = 0.6, 1H), 8.14 (td, J = 7.6, J
= 1.0, 1H), 8.23 (d, J = 7.5, 1H), 8.43 (d, J = 7.4, 1H); 13C NMR
(DMSO-d6) δ 21.1, 122.0, 122.0, 125.9, 126.1, 127.9, 130.0, 135.1,
135.8, 136.4, 136.5, 136.6, 145.1, 156.4; IR 1753, 1618; HRMS (ESI+)
3g (>99:1 E/Z, 580 mg, 82%), (S)-N-[(E)-2-(4-
methylphenylsulfonyl)ethenyl]-2,10-camphorsultam. White solid;
mp 97−98 °C; Rf = 0.68 (CH2Cl2/MeOH, 99.5:0.5); 1H NMR
(CDCl3) δ 0.95 (s, 3H), 1.02 (s, 3H), 1.31 (t, J = 8.3, 1H), 1.43 (t, J =
9.1, 1H), 1.81 (dd, J = 12.9, J = 7.9, 1H), 1.90−1.95 (m, 3H), 2.07−
2.15 (m, 1H), 2.41 (s, 3H), 3.31 (d, J = 13.9, 1H), 3.36 (d, J = 13.8,
1H), 3.48 (dd, J = 7.8, J = 4.8, 1H), 5.70 (d, J = 13.6, 1H), 7.30 (d, J =
8.2, 2H), 7.51 (d, J = 13.6, 1H), 7.74 (d, J = 8.2, 2H); 13C NMR
(CDCl3) δ 20.0, 20.4, 21.7, 26.8, 32.3, 35.9, 44.7, 48.1, 50.3, 50.7, 64.5,
110.7, 127.4, 130.0, 134.8, 139.0, 144.0; IR 1609; HRMS m/z calcd for
+
m/z calcd for C16H14NO5S2 [M + H]+ 364.0308, found 364.0314.
Purification by column chromatography was not necessary (and it is
not recommended, because of partial decomposition).
General Procedure for the Addition of Imides, Azinones,
Nucleosides, and Sultams to Tosylacetylene, To Obtain 3.
Tosylacetylene (1.2 equiv) and the corresponding substrate were
dissolved in CH3CN (0.1 M) under a N2 atmosphere. DMAP was then
added, and the reaction was stirred at 20 °C or 50 °C (see Table 3)
until TLC analysis indicated complete disappearance of the Z isomer
(usually 1 or 2 days). The solvent was removed under reduced
pressure, and the residue was dissolved in CH2Cl2. The organic layer
was washed with 0.5 M aqueous HCl and brine, dried over anhyd
MgSO4, filtered, and concentrated. Purification by flash column
chromatography on silica gel afforded pure 3.
+
C19H26NO4S2 [M + H]+ 396.1298, found 396.1293.
3h (>99:1 E/Z, 56 mg, 97%), N-[(E)-2-(4-methylphenylsulfonyl)-
ethenyl]-1,8-naphthosultam. White solid; mp 181−183 °C; Rf = 0.30
1
(CH2Cl2); H NMR (CDCl3) δ 2.44 (s, 3H), 6.72 (d, J = 13.9, 1H),
7.18 (m, 1H), 7.35 (d, J = 8.4, 2H), 7.66−7.68 (m, 2H), 7.80−7.86
(m, 1H), 7.84 (d, J = 8.4, 2H), 7.90 (d, J = 13.9, 1H), 8.02 (d, J = 7.3,
1H), 8.18 (d, J = 8.4, 1H); 13C NMR (CDCl3, 100.6 MHz) δ 21.8,
105.6, 112.5, 118.8, 120.5, 121.4, 127.6, 128.6, 128.9, 129.5, 130.1,
130.6, 131.0, 132.3, 132.5, 138.5, 144.4; IR 1622; HRMS m/z calcd for
3a (>99:1 E/Z, 1.36 g, 90%), 1-N-[(E)-2-(4-methylphenylsulfonyl)-
ethenyl]succinimide. White solid; mp 192−194 °C; Rf = 0.51
+
C19H16NO4S2 [M + H]+ 386.0515, found 386.0525.
1
(hexanes/EtOAc, 20:80); H NMR (CDCl3) δ 2.43 (s, 3H), 2.83 (s,
N-[(E)-2-(4-Methylphenylsulfonyl)ethenyl]saccharin, 3i. A solu-
tion of DMAP (4 mg, 0.03 mmol) and 2i (228 mg, 0.627 mmol) in
CH3CN (6.3 mL) was stirred overnight at rt. The solvent was
removed under reduced pressure, and the residue was purified by flash
column chromatography (hexanes:EtOAc, 1:1) to afford 3i (205 mg,
90%, >99:1 E/Z) as a White solid: mp 208−209 °C; Rf = 0.54
(hexanes/EtOAc, 1:1); 1H NMR (CDCl3) δ 2.45 (s, 3H), 6.93 (d, J =
4H), 7.33 (d, J = 8.2, 2H), 7.58 (d, J = 14.2, 1H), 7.78 (d, J = 14.2,
1H), 7.78 (d, J = 8.2, 2H); 13C NMR (CDCl3) δ 21.8, 27.9, 121.1,
127.8, 128.5, 130.1, 137.7, 144.7, 174.1; IR 1731, 1622; HRMS m/z
calcd for C13H14NO4S+ [M + H]+ 280.0638, found 280.0632.
3b (>99:1 E/Z, 1.47 g, 98%), N-[(E)-2-(4-methylphenylsulfonyl)-
ethenyl]phthalimide. White solid; mp 186−187 °C; Rf = 0.77
(CH2Cl2/MeOH, 99:1); 1H NMR (CDCl3) δ 2.43 (s, 3H), 7.34 (d, J
8831
dx.doi.org/10.1021/jo501647w | J. Org. Chem. 2014, 79, 8826−8834